What is the Ownership and Shareholding Structure of Synorga Pharmaceuticals?
In 2017, Synorga Pharmaceuticals had a promoter holding of 6.20% and a public holding of 93.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX